A multicenter, open-label phase II study to evaluate the efficacy and safety of pimicotinib (CSF-1R inhibitor) in combination with chemotherapy with or without toripalimab in patients (pts) with advanced pancreatic ductal adenocarcinoma (aPDAC)

被引：0
|
作者：
Zhang, X. [1 ]
Cui, J. [1 ]
Quan, M. [2 ]
Zhang, T. [3 ]
Cao, D. [4 ]
Li, Z. [5 ]
Yang, D. T. C. [6 ]
Zhu, X. [6 ]
Chen, Y. [6 ]
Liang, P. [6 ]
Yao, L. [6 ]
Wang, L. [1 ]
机构：
[1] Shanghai Jiao Tong Univ, Renji Hosp, Dept Oncol, Sch Med, Shanghai, Peoples R China
[2] Tongji Univ, Dept Oncol, Shanghai East Oriental Hosp, Shanghai, Peoples R China
[3] Huazhong Univ Sci & Technol, Dept Oncol, Union Hosp Tongji Med Coll, Wuhan, Peoples R China
[4] Sichuan Univ, Abdominal Oncol, West China Hosp, Chengdu, Peoples R China
[5] Harbin Med Univ, Dept Oncol, Canc Hosp, Harbin, Peoples R China
[6] Abbisko Therapeut Co Ltd, Clin Dev, Shanghai, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2024年 / 35卷
关键词：
D O I：
10.1016/j.annonc.2024.08.1596
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1533TiP
引用
收藏
页码：S934 / S935
页数：2
相关论文
共 50 条
  • [41] TORNADO: A randomized multicenter open-label phase II study evaluating retifanlimab in combination with neoadjuvant chemotherapy in patients with selected retroperitoneal sarcomas
    Albert, S.
    Italiano, A.
    Toulmonde, M.
    Cousin, S.
    Bahleda, R.
    Brahmi, M.
    Watson, S.
    Auzanneau, C.
    Douiri, N.
    Poignie, L.
    Lortal, B.
    Le Loarer, F.
    Bellera, C.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S1242 - S1243
  • [42] Open-label, multicenter Phase II Study to Investigate the Efficacy and Safety of Domatinostat in Combination with Avelumab in Patients with treatment-naive, metastatic Merkel Cell Carcinoma - the MERKLIN 1 Study
    Terheyden, P.
    van Akkooi, A.
    Ascierto, P. A.
    Nghiem, P.
    Henneberg, J.
    Hermann, F.
    Becker, J. C.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2021, 19 : 45 - 46
  • [43] An open-label phase I study to evaluate the safety, tolerability and preliminary efficacy of YY001 in patients with advanced solid tumors
    Xue, Liqiong
    Tang, Wenbo
    Zhou, Huan
    Liu, Mulin
    Liu, Yuanyuan
    Wang, Jinhua
    Chen, Jianfeng
    Liu, Mingyao
    Guo, Ye
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [44] Neoadjuvant PD-1 inhibitor (toripalimab) plus chemotherapy in patients with potentially resectable NSCLC: An open-label, single-arm, phase II trial
    Zhu, X.
    Sun, L.
    Song, N.
    Sun, F.
    Yang, J.
    Duan, L.
    Zhao, D.
    He, W.
    Luo, J.
    Zhang, H.
    Wu, C.
    Zhu, Y.
    Zhang, P.
    Jiang, G.
    ANNALS OF ONCOLOGY, 2021, 32 : S942 - S942
  • [45] A multicenter, randomized, open-label, comparative, phase IV study to evaluate the efficacy and safety of combined treatment with mycophenolate mofetil and corticosteroids in advanced immunoglobulin A nephropathy
    Han, Sang Youb
    Jung, Chan-Young
    Lee, Sang Ho
    Lee, Dong Won
    Lee, Sik
    Kim, Chan-Duck
    Choi, Bum Soon
    Kim, Beom Seok
    KIDNEY RESEARCH AND CLINICAL PRACTICE, 2022, 41 (04) : 452 - 461
  • [46] A Multicenter, Open-Label, Phase 1 Study Evaluating the Safety and Tolerability of Pegaspargase in Combination with Gemcitabine in Advanced Metastatic Solid Tumors and Lymphoma
    Borad, Mitesh J.
    Babiker, Hani M.
    Anthony, Stephen
    Mita, Monica
    Buchbinder, Aby
    Keilani, Taha
    Grem, Jean
    CANCER INVESTIGATION, 2015, 33 (05) : 172 - 179
  • [47] A phase II open-label study of enfortumab vedotin in patients with previously treated locally advanced, recurrent, or metastatic pancreatic adenocarcinoma (EPIC).
    Kasi, Anup
    Phadnis, Milind A.
    Al-Rajabi, Raed Moh'd Taiseer
    Baranda, Joaquina Celebre
    Li, Haoran
    Carroll, Erin
    Belcher, Cathey
    Bradbury, Shannon
    Collins, Zachary
    Sun, Weijing
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : TPS719 - TPS719
  • [48] OPEN-LABEL, PHASE 1 SAFETY AND PHARMACOKINETIC STUDY TO EVALUATE RUCAPARIB IN JAPANESE PATIENTS WITH A PREVIOUSLY TREATED ADVANCED SOLID TUMOUR
    Tamura, K.
    Matsumoto, K.
    Hasegawa, K.
    Nishikawa, T.
    Shimomura, A.
    Sudo, K.
    Isaacson, J.
    Jones, E.
    Giordano, H.
    Fujiwara, K.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 : 1021 - 1021
  • [49] Efficacy and safety of chiauranib in a combination therapy in platinum-resistant or refractory ovarian cancer: a multicenter, open-label, phase Ib and II study
    Li, Jin
    Liu, Jihong
    Yin, Rutie
    Zou, Dongling
    Zheng, Hong
    Cao, Junning
    Chen, Zhendong
    Sun, Wei
    Gao, Yunong
    Zhang, Songling
    Zeng, Linjuan
    An, Ruifang
    Lu, Xianping
    Ye, Shuang
    Wu, Xiaohua
    MOLECULAR CANCER, 2024, 23 (01)
  • [50] A Multicenter, Open-Label, Single-Arm, Phase 2 Study to Evaluate the Efficacy and Safety of Hetrombopag in Patients with Severe Aplastic Anemia (SAA)
    Zhang, Fengkui
    Peng, Guangxin
    He, Guangsheng
    Chang, Hong
    Gao, Sujun
    Liu, Xinjian
    Chen, Tong
    Li, Pei
    Han, Bing
    Miao, Miao
    Ge, Zheng
    Ge, Xiaoyan
    Li, Fei
    Li, Yingmei
    Wang, Shunqing
    Wang, Yi
    Shen, Yaqi
    Tai, Yanfei
    Zhang, Tao
    Zhu, Bo
    Zou, Jianjun
    BLOOD, 2020, 136
12345